DAVID ALTSHULER - 08 Aug 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Global Research and CSO
Signature
/s/ Joy Liu, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
08 Aug 2022
Net transactions value
-$136,930
Form type
4
Filing time
10 Aug 2022, 16:06:06 UTC
Previous filing
21 Jul 2022
Next filing
09 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $244,539 +1,304 +3.6% $187.53 37,381 08 Aug 2022 Direct
transaction VRTX Common Stock Sale $64,451 -222 -0.59% $290.32 37,159 08 Aug 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $123,609 -424 -1.1% $291.53 36,735 08 Aug 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale $61,534 -210 -0.57% $293.02 36,525 08 Aug 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale $88,785 -302 -0.83% $293.99 36,223 08 Aug 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale $43,090 -146 -0.4% $295.14 36,077 08 Aug 2022 Direct F1, F2, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -1,304 -33% $0.000000 2,607 08 Aug 2022 Common Stock 1,304 $187.53 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
F2 Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $290.32 (range $290.05 to $290.64).
F4 Open market sales reported on this line occurred at a weighted average price of $291.53 (range $291.06 to $291.91).
F5 Open market sales reported on this line occurred at a weighted average price of $293.02 (range $292.41 to $293.36).
F6 Open market sales reported on this line occurred at a weighted average price of $293.99 (range $293.58 to $294.26).
F7 Open market sales reported on this line occurred at a weighted average price of $295.14 (range $294.74 to $295.53).
F8 The option vests in 16 quarterly installments from 2/6/2019.